Submitting a manuscript to the American Journal of PharmTech Research (AJPTR) signifies that the research paper has not been previously published and is not under consideration for publication in any other journal or platform. Authors must ensure that their work is original, unpublished, and not simultaneously submitted elsewhere to maintain the integrity of the publication process.
Once a manuscript is accepted for publication, the corresponding author will receive a Copyright Transfer Agreement (CTA) form via email. This form is a mandatory requirement for publication and must be duly completed and signed by the author and all co-authors.
Ensuring timely submission of the signed CTA form is essential to avoid delays in the publication process. For any queries regarding manuscript submission, copyright policies, or publication charges, authors can contact the editorial office via email.